Time to complete:
5 minutes
Date of publication:
April 2021

COVID-19 has transformed the way that we work in primary care, with remote consulting becoming much more common. In this short screencast we discuss how you can safely assess patients with rheumatological conditions remotely and how to decide when this isn’t safe and a face to face assessment should be arranged. 

Supported by an independent education grant from Pfizer Inc. Pfizer has had no involvement in the content.